In more specific terms, critical regulatory effect of Gab2 on SHP2 has been established by several studies [25] and deregulation of this interaction is known to be associated with chronic myeloid leukemia (CML) [26]. The gene discussed is GAB2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.